Macrophage migration inhibitory factor (MIF) gene is associated with adolescents’ cortisol reactivity and anxiety. / Lipschutz, Rebecca; Bick, Johanna; Nguyen, Victoria; Lee, Maria; Leng, Lin; Grigorenko, Elena; Bucala, Richard; Mayes, Linda C.; Crowley, Michael J.
In: Psychoneuroendocrinology, Vol. 95, 09.2018, p. 170-178.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Macrophage migration inhibitory factor (MIF) gene is associated with adolescents’ cortisol reactivity and anxiety
AU - Lipschutz, Rebecca
AU - Bick, Johanna
AU - Nguyen, Victoria
AU - Lee, Maria
AU - Leng, Lin
AU - Grigorenko, Elena
AU - Bucala, Richard
AU - Mayes, Linda C.
AU - Crowley, Michael J.
PY - 2018/9
Y1 - 2018/9
N2 - Emerging evidence points to interactions between inflammatory markers and stress reactivity in predicting mental health risk, but underlying mechanisms are not well understood. Macrophage Migration Inhibitory Factor (MIF) is a pleiotropic cytokine involved in inflammatory signaling and Hypothalamus Pituitary Adrenal (HPA) axis stress-response, and has recently been identified as a candidate biomarker for depression and anxiety risk. We examined polymorphic variations of the MIF gene in association with baseline MIF levels, HPA axis reactivity, and self-reported anxiety responses to a social stressor in 74 adolescents, ages 10–14 years. Genotyping was performed for two polymorphisms, the -794 CATT5-8 tetranucleotide repeat and the -173*G/C single nucleotide polymorphism (SNP). Youth carrying the MIF-173*C and CATT7 alleles displayed attenuated cortisol reactivity when compared with non-carriers. Children with the CATT7-173*C haplotype displayed lower cortisol reactivity to the stressor compared to those without this haplotype. Additionally, the CATT5-173*C and CATT6-173*C haplotypes were associated with lower self-reported anxiety ratings across the stressor. Results extend prior work pointing to the influence of MIF signaling on neuroendocrine response to stress and suggest a potential pathophysiological pathway underlying risk for stress-related physical and mental health disorders. To our knowledge, these are the first data showing associations between the MIF gene, HPA axis reactivity, and anxiety symptoms during adolescence.
AB - Emerging evidence points to interactions between inflammatory markers and stress reactivity in predicting mental health risk, but underlying mechanisms are not well understood. Macrophage Migration Inhibitory Factor (MIF) is a pleiotropic cytokine involved in inflammatory signaling and Hypothalamus Pituitary Adrenal (HPA) axis stress-response, and has recently been identified as a candidate biomarker for depression and anxiety risk. We examined polymorphic variations of the MIF gene in association with baseline MIF levels, HPA axis reactivity, and self-reported anxiety responses to a social stressor in 74 adolescents, ages 10–14 years. Genotyping was performed for two polymorphisms, the -794 CATT5-8 tetranucleotide repeat and the -173*G/C single nucleotide polymorphism (SNP). Youth carrying the MIF-173*C and CATT7 alleles displayed attenuated cortisol reactivity when compared with non-carriers. Children with the CATT7-173*C haplotype displayed lower cortisol reactivity to the stressor compared to those without this haplotype. Additionally, the CATT5-173*C and CATT6-173*C haplotypes were associated with lower self-reported anxiety ratings across the stressor. Results extend prior work pointing to the influence of MIF signaling on neuroendocrine response to stress and suggest a potential pathophysiological pathway underlying risk for stress-related physical and mental health disorders. To our knowledge, these are the first data showing associations between the MIF gene, HPA axis reactivity, and anxiety symptoms during adolescence.
KW - Adolescents
KW - Anxiety
KW - Cortisol
KW - Cytokine
KW - HPA-axis
KW - MIF
KW - Stress reactivity
KW - Stress response
UR - http://www.scopus.com/inward/record.url?scp=85047827636&partnerID=8YFLogxK
U2 - 10.1016/j.psyneuen.2018.05.033
DO - 10.1016/j.psyneuen.2018.05.033
M3 - Article
C2 - 29870971
AN - SCOPUS:85047827636
VL - 95
SP - 170
EP - 178
JO - Psychoneuroendocrinology
JF - Psychoneuroendocrinology
SN - 0306-4530
ER -
ID: 62763424